World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 14

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9887)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

723

WORD

318

HTML

5280

Figures (1-3)

984

Tables (1-3)

619

Sum=7924

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

582

Download

1381

Sum=1963

Apr 14, 2021 (publication date) through Dec 17, 2025

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Goh ZY, Ren EC, Ko HL. Intracellular interferon signalling pathways as potential regulators of covalently closed circular DNA in the treatment of chronic hepatitis B. World J Gastroenterol 2021; 27(14): 1369-1391 [PMID: 33911462 DOI: 10.3748/wjg.v27.i14.1369]
URL:	https://www.wjgnet.com/1007-9327/full/v27/i14/1369.htm

Number	Citing Articles
1	Yi He, Yingzhi Zhou, Huimin Wang, Xiaorong Peng, Yunan Chang, Peng Hu, Hong Ren, Hongmei Xu. The efficacy of pegylated interferon alpha-2a and entecavir in HBeAg-positive children and adolescents with chronic hepatitis B. BMC Pediatrics 2022; 22(1) doi: 10.1186/s12887-022-03482-0
2	Feng Chen, Zhenhua Zhou, Liu Zhuang, Rongrong Zou, Yingfei Wen, Xinyi Deng. Clinical treatment outcomes of chronic hepatitis B pediatric with coexistence of HBeAg and HBeAb. Scandinavian Journal of Gastroenterology 2025; : 1 doi: 10.1080/00365521.2025.2594789
3	Guo-Qing Yin, Ke-Ping Chen, Xiao-Chun Gu. Heterogeneity of immune control in chronic hepatitis B virus infection: Clinical implications on immunity with interferon-α treatment and retreatment. World Journal of Gastroenterology 2022; 28(40): 5784-5800 doi: 10.3748/wjg.v28.i40.5784 Abstract(1008) \| Core Tip(944) \| Full Article(HTML)(4733) \| Full Article (PDF)-1652K(387) \| Full Article (Word)-901K(55) \| Audio-8749K(11) \| Peer-Review Report-223K(168) \| Answering Reviewers-149K(179) \| Times Cited (2) \| Total Visits (11515) \| Open
4	Zhijing Yang, Baozhen Sun, Jingcheng Xiang, Han Wu, Shaoning Kan, Ming Hao, Lu Chang, Huimin Liu, Dongxu Wang, Weiwei Liu. Role of epigenetic modification in interferon treatment of hepatitis B virus infection. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1018053
5	Meda Cosma, Teodora Mocan, Lavinia Ioana Sabau, Teodora Pop, Ofelia Mosteanu, Lucian Mocan. A Narrative Review on Functionalized Nanoparticles for the Treatment and Early Detection of Hepatocellular Carcinoma. Applied Sciences 2025; 15(14): 7649 doi: 10.3390/app15147649